Q1 2017
Released May 4, 2017, after the close
10-Q filed May 4, 2017, 34 days after period end · 0001237831-17-000020
Q1 2017 · 10-Q
Revenue$155.81M$155.81M +11.9% vs Q1 2016+2.8% vs Q4 2016
Net Income$28.71M$28.71M +2.5% vs Q1 2016+18.2% vs Q4 2016
EPS Diluted$0.30$0.30 +3.4% vs Q1 2016+20.0% vs Q4 2016
Gross Profit$120,209,000+11.6%
Operating Income$40,314,000−5.9%
Operating Cash Flow$53,449,000−3.8%
Free Cash Flowderived$41,916,000−9.3%
Margins · derived
Gross margin77.2%−0.2 pt vs Q1 2016
Operating margin25.9%−4.9 pt vs Q1 2016
Net margin18.4%−1.7 pt vs Q1 2016
What the release said
No earnings release is on file for this quarter. Its figures came with the 10-Q.
Same quarter
| Metric | Q1 2017 | Q1 2016 | Q1 2015 | Q1 2014 |
|---|---|---|---|---|
| Revenue | $155.81M | $139.26M | $131.60M | $114.21M |
| Net Income | $28.71M | $28.01M | $24.65M | $21.14M |
| EPS Diluted | $0.30 | $0.29 | $0.26 | $0.22 |
The same fiscal quarter, prior years. Thaler holds no estimates to compare against.
Globus Medical Inc · CIK 1237831 · Engraved from SEC EDGAR